Prevymis (letermovir) - Merck (MSD)
Yescarta (axicabtagene ciloleucel) - Gilead
Single Arm Pilot Trial of Letermovir for CMV Prophy in CAR T Cell (clinicaltrials.gov) - Aug 8, 2026 - P2 | N=36 | Recruiting | Sponsor: M.D. Anderson Cancer Center | Trial completion date: Aug 2027 ➔ Aug 2028 | Trial primary completion date: Aug 2026 ➔ Aug 2028 
Trial completion date • Trial primary completion date • Cytomegalovirus Infection • Hematological Malignancies
http://clinicaltrials.gov/ct2/show/NCT06575374
 
Aug 8, 2026
 
Prev Next